- Home
- HQI vs VXRT Comparison
HQI vs VXRT Comparison
Compare HQI & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- VXRT
- Stock Information
- Founded
- HQI 2002
- VXRT N/A
- Country
- HQI United States
- VXRT United States
- Employees
- HQI N/A
- VXRT N/A
- Industry
- HQI Professional Services
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HQI Consumer Discretionary
- VXRT Health Care
- Exchange
- HQI Nasdaq
- VXRT Nasdaq
- Market Cap
- HQI 196.4M
- VXRT 200.3M
- IPO Year
- HQI N/A
- VXRT N/A
- Fundamental
- Price
- HQI $12.65
- VXRT $0.74
- Analyst Decision
- HQI Strong Buy
- VXRT Strong Buy
- Analyst Count
- HQI 2
- VXRT 2
- Target Price
- HQI $18.50
- VXRT $3.00
- AVG Volume (30 Days)
- HQI 11.0K
- VXRT 2.6M
- Earning Date
- HQI 11-07-2024
- VXRT 03-13-2025
- Dividend Yield
- HQI 1.90%
- VXRT N/A
- EPS Growth
- HQI N/A
- VXRT N/A
- EPS
- HQI 0.10
- VXRT N/A
- Revenue
- HQI $36,279,000.00
- VXRT $16,760,000.00
- Revenue This Year
- HQI N/A
- VXRT $128.43
- Revenue Next Year
- HQI $8.39
- VXRT N/A
- P/E Ratio
- HQI $89.93
- VXRT N/A
- Revenue Growth
- HQI 0.28
- VXRT 303.27
- 52 Week Low
- HQI $11.39
- VXRT $0.52
- 52 Week High
- HQI $15.75
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- HQI 38.90
- VXRT 52.85
- Support Level
- HQI $12.42
- VXRT $0.70
- Resistance Level
- HQI $13.69
- VXRT $0.83
- Average True Range (ATR)
- HQI 0.62
- VXRT 0.10
- MACD
- HQI -0.07
- VXRT -0.00
- Stochastic Oscillator
- HQI 10.14
- VXRT 36.84
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.